Metropolis Healthcare Statistics
Total Valuation
Metropolis Healthcare has a market cap or net worth of INR 94.65 billion. The enterprise value is 94.74 billion.
Market Cap | 94.65B |
Enterprise Value | 94.74B |
Important Dates
The next estimated earnings date is Friday, February 7, 2025.
Earnings Date | Feb 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Metropolis Healthcare has 51.27 million shares outstanding. The number of shares has increased by 0.13% in one year.
Current Share Class | n/a |
Shares Outstanding | 51.27M |
Shares Change (YoY) | +0.13% |
Shares Change (QoQ) | +0.05% |
Owned by Insiders (%) | 18.80% |
Owned by Institutions (%) | 51.16% |
Float | 25.94M |
Valuation Ratios
The trailing PE ratio is 64.16 and the forward PE ratio is 47.30. Metropolis Healthcare's PEG ratio is 2.39.
PE Ratio | 64.16 |
Forward PE | 47.30 |
PS Ratio | 7.36 |
PB Ratio | 7.99 |
P/TBV Ratio | 27.27 |
P/FCF Ratio | 41.78 |
P/OCF Ratio | n/a |
PEG Ratio | 2.39 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.49, with an EV/FCF ratio of 41.82.
EV / Earnings | 64.00 |
EV / Sales | 7.37 |
EV / EBITDA | 30.49 |
EV / EBIT | 43.71 |
EV / FCF | 41.82 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.16.
Current Ratio | 1.64 |
Quick Ratio | 1.34 |
Debt / Equity | 0.16 |
Debt / EBITDA | 0.61 |
Debt / FCF | 0.84 |
Interest Coverage | 10.67 |
Financial Efficiency
Return on equity (ROE) is 13.29% and return on invested capital (ROIC) is 10.20%.
Return on Equity (ROE) | 13.29% |
Return on Assets (ROA) | 8.63% |
Return on Capital (ROIC) | 10.20% |
Revenue Per Employee | 2.98M |
Profits Per Employee | 343,221 |
Employee Count | 4,313 |
Asset Turnover | 0.82 |
Inventory Turnover | 7.04 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.14% in the last 52 weeks. The beta is 0.34, so Metropolis Healthcare's price volatility has been lower than the market average.
Beta (5Y) | 0.34 |
52-Week Price Change | +15.14% |
50-Day Moving Average | 2,059.91 |
200-Day Moving Average | 2,035.21 |
Relative Strength Index (RSI) | 25.94 |
Average Volume (20 Days) | 151,915 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Metropolis Healthcare had revenue of INR 12.85 billion and earned 1.48 billion in profits. Earnings per share was 28.77.
Revenue | 12.85B |
Gross Profit | 10.01B |
Operating Income | 2.17B |
Pretax Income | 2.00B |
Net Income | 1.48B |
EBITDA | 2.49B |
EBIT | 2.17B |
Earnings Per Share (EPS) | 28.77 |
Balance Sheet
The company has 1.85 billion in cash and 1.89 billion in debt, giving a net cash position of -49.38 million or -0.96 per share.
Cash & Cash Equivalents | 1.85B |
Total Debt | 1.89B |
Net Cash | -49.38M |
Net Cash Per Share | -0.96 |
Equity (Book Value) | 11.87B |
Book Value Per Share | 231.09 |
Working Capital | 1.53B |
Cash Flow
In the last 12 months, operating cash flow was 2.76 billion and capital expenditures -491.13 million, giving a free cash flow of 2.27 billion.
Operating Cash Flow | 2.76B |
Capital Expenditures | -491.13M |
Free Cash Flow | 2.27B |
FCF Per Share | 44.19 |
Margins
Gross margin is 77.88%, with operating and profit margins of 16.86% and 11.52%.
Gross Margin | 77.88% |
Operating Margin | 16.86% |
Pretax Margin | 15.55% |
Profit Margin | 11.52% |
EBITDA Margin | 19.34% |
EBIT Margin | 16.86% |
FCF Margin | 17.63% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.22%.
Dividend Per Share | 4.00 |
Dividend Yield | 0.22% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 13.85% |
Buyback Yield | -0.13% |
Shareholder Yield | 0.09% |
Earnings Yield | 1.56% |
FCF Yield | 2.39% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |